| Page | |
|---|---|
| Balance Sheet | 1—2 |
| Notes to the Financial Statements | 3—4 |
| 2025 | 2024 | ||||
|---|---|---|---|---|---|
| Notes | £ | £ | £ | £ | |
| FIXED ASSETS | |||||
| Tangible Assets | 4 |
|
|
||
| Investment Properties | 5 |
|
|
||
|
|
|
||||
| CURRENT ASSETS | |||||
| Debtors | 6 |
|
|
||
| Cash at bank and in hand |
|
|
|||
|
|
|
||||
| Creditors: Amounts Falling Due Within One Year | 7 |
( |
( |
||
| NET CURRENT ASSETS (LIABILITIES) |
( |
( |
|||
| TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
( |
|||
| NET LIABILITIES |
( |
( |
|||
| CAPITAL AND RESERVES | |||||
| Called up share capital | 8 |
|
|
||
| Profit and Loss Account |
( |
( |
|||
| SHAREHOLDERS' FUNDS | (606,115) | (574,098) | |||
|
Director
|
|
|
| Plant & Machinery |
|
| Plant & Machinery | |
|---|---|
| £ | |
| Cost | |
| As at 1 April 2024 |
|
| Additions |
|
| As at 31 March 2025 |
|
| Depreciation | |
| As at 1 April 2024 |
|
| Provided during the period |
|
| As at 31 March 2025 |
|
| Net Book Value | |
| As at 31 March 2025 |
|
| As at 1 April 2024 |
|
| 2025 | |
|---|---|
| £ | |
| Fair Value | |
| As at 1 April 2024 and 31 March 2025 |
|
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Cost | 1,212,856 | 1,212,856 | |
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Due within one year | |||
| Other debtors | 51,566 | 61,924 | |
| 2025 | 2024 | ||
|---|---|---|---|
| £ | £ | ||
| Trade creditors |
|
|
|
| Amounts owed to participating interests |
|
|
|
| Other creditors | 50,277 | 53,454 | |
|
|
|
||
Kalmax International Ltd
A total of £1,297,367 (2024: £1,290,000) has been borrowed from Kalmax International Ltd, a company which owns 50% of the issued share capital. The loan is secured upon the freehold property of the company, is interest free and repayable on demand.
Antidote Projects Ltd
A total of £11,000 (2024: £0) has been borrowed from Antidote Projects Ltd, a company under common control. The loan is interest free and repayable on demand.